These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 23348972)

  • 1. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.
    Tunney MM; Einarsson GG; Wei L; Drain M; Klem ER; Cardwell C; Ennis M; Boucher RC; Wolfgang MC; Elborn JS
    Am J Respir Crit Care Med; 2013 May; 187(10):1118-26. PubMed ID: 23348972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
    Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ
    Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis.
    Byun MK; Chang J; Kim HJ; Jeong SH
    PLoS One; 2017; 12(8):e0183553. PubMed ID: 28829833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.
    Fodor AA; Klem ER; Gilpin DF; Elborn JS; Boucher RC; Tunney MM; Wolfgang MC
    PLoS One; 2012; 7(9):e45001. PubMed ID: 23049765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
    Rogers GB; van der Gast CJ; Cuthbertson L; Thomson SK; Bruce KD; Martin ML; Serisier DJ
    Thorax; 2013 Aug; 68(8):731-7. PubMed ID: 23564400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymicrobial airway bacterial communities in adult bronchiectasis patients.
    Purcell P; Jary H; Perry A; Perry JD; Stewart CJ; Nelson A; Lanyon C; Smith DL; Cummings SP; De Soyza A
    BMC Microbiol; 2014 May; 14():130. PubMed ID: 24886473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.
    Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD
    Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.
    Zemanick ET; Harris JK; Wagner BD; Robertson CE; Sagel SD; Stevens MJ; Accurso FJ; Laguna TA
    PLoS One; 2013; 8(4):e62917. PubMed ID: 23646159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Respiratory pathogen spectrum in pulmonary exacerbation of bronchiectasis in adults and its association with disease severity].
    Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):254-261. PubMed ID: 30955282
    [No Abstract]   [Full Text] [Related]  

  • 11. Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance.
    McDonnell MJ; Jary HR; Perry A; MacFarlane JG; Hester KL; Small T; Molyneux C; Perry JD; Walton KE; De Soyza A
    Respir Med; 2015 Jun; 109(6):716-26. PubMed ID: 25200914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway "Resistotypes" and Clinical Outcomes in Bronchiectasis.
    Mac Aogáin M; Ivan FX; Jaggi TK; Richardson H; Shoemark A; Narayana JK; Dicker AJ; Koh MS; Lee KCH; Thun How O; Poh ME; Chin KK; Hou ALY; Ser Hon P; Low TB; Abisheganaden JA; Dimakou K; Digalaki A; Kosti C; Gkousiou A; Hansbro PM; Blasi F; Aliberti S; Chalmers JD; Chotirmall SH
    Am J Respir Crit Care Med; 2024 Jul; 210(1):47-62. PubMed ID: 38271608
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of lung function impairment in adults with bronchiectasis.
    Guan WJ; Gao YH; Xu G; Lin ZY; Tang Y; Li HM; Lin ZM; Zheng JP; Chen RC; Zhong NS
    PLoS One; 2014; 9(11):e113373. PubMed ID: 25405614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients.
    Cox MJ; Turek EM; Hennessy C; Mirza GK; James PL; Coleman M; Jones A; Wilson R; Bilton D; Cookson WO; Moffatt MF; Loebinger MR
    PLoS One; 2017; 12(2):e0170622. PubMed ID: 28170403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort Study.
    Gao Y; Richardson H; Dicker AJ; Barton A; Kuzmanova E; Shteinberg M; Perea L; Goeminne PC; Cant E; Hennayake C; Pollock J; Abo Leyah H; Choi H; Polverino E; Blasi F; Welte T; Aliberti S; Long M; Shoemark A; Sibila O; Huang JTJ; Chalmers JD
    Am J Respir Crit Care Med; 2024 Jul; 210(1):77-86. PubMed ID: 38717347
    [No Abstract]   [Full Text] [Related]  

  • 16. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
    Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
    Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lung microbiome in children with HIV-bronchiectasis: a cross-sectional pilot study.
    Masekela R; Vosloo S; Venter SN; de Beer WZ; Green RJ
    BMC Pulm Med; 2018 May; 18(1):87. PubMed ID: 29788934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic Upper and Lower Airway Microbiotas in Paediatric Bronchiectasis Exacerbations: A Pilot Study.
    Broderick DTJ; Regtien T; Ainsworth A; Taylor MW; Pillarisetti N
    Front Cell Infect Microbiol; 2021; 11():773496. PubMed ID: 35141165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D; Henig N; Morrissey B; Gotfried M
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation.
    Carmody LA; Zhao J; Schloss PD; Petrosino JF; Murray S; Young VB; Li JZ; LiPuma JJ
    Ann Am Thorac Soc; 2013 Jun; 10(3):179-87. PubMed ID: 23802813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.